1. 020 门诊 CLINIC
东闻视野·国际瞭望 outlook
Fausto Pinto
Professor, FESC
ESC President 2014-2016
Lisbon University Medical School,
Department of Cardiology
Photographer: BingZhang
2. 021门诊 CLINIC
ESC President Interview 海外学会主席访谈
In the 2015 CSC&OCC Conference, Clinic interviewed the current president of the European Society of Cardiology
(ESC) Prof. Fausto Pinto. In the interview, we talked about the main contribution ESC has made to the cardiovascular
field in Europe and worldwide, ESC's significant strategy, and the fruitful collaboration between the ESC and Chinese
communities.
Especially, Dr. Pinto declared that one of the ESC’s main strategic decisions was continual support of education as well as
a strong advocacy strategy. For doing so, “we also do work in advocacy and lobbying with several European structures
such as the European Union as well as the European Parliament,” noted Dr. Pinto. Additionally, Dr. Pinto told Clinic, the
ultimate goal of ESC is not only to stand as one of the main cardiovascular education providers but to also be the voice of
the patients and entire cardiovascular community.
November: Clinic·Cardiology continually presents the oversea President’s interview with the ESC President.
ESC: A Main Contributor to
Cardiovascular Development
Dr. Fausto Pinto
dedicated to treatment, while only 3% is dedicated to prevention.
Thus, prevention is one key area where we, as a scientific society
and community, must do more. We must be dedicated to smoking
cessation, fighting obesity and diabetes, controlling blood
pressure, and promoting overall healthy lifestyles in order to truly
increase prevention of cardiovascular disease.The prevention field
is lacking most and requires further action.
Clinic: In what action do you think does ESC contribute
to prevention?
Dr. Pinto: It is imperative to increase awareness of the disease.
This requires advocacy as well as lobbying in order to work
jointly with decision makers. We are currently involved in such
Clinic: The cardiovascular field has developed over the
past half-century. In such a background, what is lacking
most currently?
Dr. Pinto: Over the past decades, the cardiovascular field and
its subfields have substantially developed. Many of the sub-
specialties such as PCI, radiology, heart failure, acute coronary
syndrome, dyslipidemia, diagnoses and imaging have seen major
development. I think the area that is currently lacking most is
prevention. Cardiologists are extremely skilled at diagnosing and
treating the disease; however, we are lacking in preventing the
disease. This is definitely an area in need of improvement.
For example, 97% of the overall budget for health in Europe is
3. 022 门诊 CLINIC
东闻视野·国际瞭望 outlook
action in Europe. There we ensure that all of the information on
the disease is conveyed to the decision makers.
Furthermore, we must work with patient populations and the
media to ensure that the message of cardiovascular disease is
propagated. In doing so, we must propagate the message in a
positive way for the promotion of healthy lifestyles and healthy
habits to result in people living longer and better lives.
Clinic: We know that ESC is the largest cardiovascular
society in the world. What is the most significant impact
of ESC on European clinics? What has it contributed to
this field?
Dr. Pinto: The European Society of Cardiology is now the
largest cardiovascular society in the world with roughly 90,000
health professional members. The society’s mission stands
to reduce the burden of cardiovascular disease in Europe and
worldwide. We do so through a myriad of activities and education
programs. Our main congress, which was recently held in London,
is the largest event in cardiovascular medicine in the world as
nearly 33,000 members participated in the congress. We also
organize additional meetings and educational activities throughout
the year in different sub specialties. We have a large, web-based
educational platform, where people can access information for
education, training, and certification.
Additionally, we organize and promote five new guidelines each
year for patient management to help clinicians provide better
patient management.
The society also organizes registries with our full registry program
entitled the Euro Observational Research Program (EORP).
Currently, the society has about twenty programs running that
cover the entire field of cardiovascular medicine. The goal of
the registries serves to create a landscape of the cardiovascular
field in Europe and throughout the world. With the registries, we
intend to better understand how well we are preventing disease
and implementing guidelines. These are very powerful tools to
understand how patients are being treated in the real world.
We also do work in advocacy and lobbying with several European
structures such as the European Union as well as the European
Parliament. Our current focus is to get involved in multiple
communities in order to increase awareness of cardiovascular
disease and to help improve cardiovascular management.
In whole, there is a whole set of activities that we do in Europe
and, now, in other parts of the world. We are here in China so that
we can learn from each other to improve the way we treat our
patients and populations.
Clinic: It is great to hear that you contribute to so many
activities. How do you produce innovation in Europe?
How do you support the training of young physicians?
Dr. Pinto: Educating young physicians is another part of our
project. We hope to involve the younger generation at an early
stage so that they may substantially contribute to the society.
In order to do so, we have a program dedicated to young
cardiologists entitled "The Cardiologists of Tomorrow".
In terms of innovation, we work particularly at the central level to
promote innovation in the cardiovascular field in pharmacology
4. 023门诊 CLINIC
ESC President Interview 海外学会主席访谈
and devices. The ESC also advocates for the need to support
innovation in the cardiovascular field. We advocate that it is
imperative for key decision makers to support innovation in order
to spur further development in the cardiovascular field.
During the past decade, many innovations have occurred in
Europe. I hope this trend will continue to be so prosperous.
However, even so, we must continue to demonstrate the need
to support cardiovascular medicine – both for research and
clinical practice. It is extremely important to continue to support
innovation and research in the cardiovascular field in order to
understand the gaps and unknown areas in the field. This is why
we still have a lot of people who are committed to cardiovascular
disease.
Clinic: As the president of ESC, what do you think is
the next most significant strategy of ESC?
Dr. Pinto: I think that one of the ESC’s main strategic
decisions was to continue to support an increase in awareness of
cardiovascular disease, to continue to support education, and to
have a strong advocacy strategy.
In order to do so, we have developed a five-year strategic plan,
in which we cover five areas – advocacy, education, congresses,
research, and membership. Our main priority remains to ensure
that we provide the best for our members. We are initiating a new
membership process in order to promote closer contact with our
members and engage them in activities of the society.
The society must continue to strengthen our education and
advocacy platforms in order to gain continued support for
our activities and research in the cardiovascular field. Our
ultimate goal is not only for the ESC to stand as one of the main
cardiovascular education providers but to also be the voice of the
the patients and entire cardiovascular community.
Clinic: In the future, will the ESC collaborate more with
China? Is there any detailed strategy or program by
now?
Dr. Pinto: Absolutely; since the establishment of this
cooperation between the ESC and China, our relations have only
grown stronger. We now have a project entitled the Sino-European
College. The College is with five different schools on different
topics including an imaging school, anti-coagulation school,
hypertension school, ischemic heart disease school, PCI school, as
well as a lipid management school. Each school has two chairs –
one Chinese and one European.
The Sino-European College has both joint online and offline
educational activities, which are done partly by Chinese
colleagues and partly by European colleagues. We have also
developed offline courses including European and Chinese
speaker tours that will travel to different campuses in different
cities. The development of these schools has taken place over the
past year. We highly encourage such programs, as our goal is to
ensure the continuation of our relationship with China.
In addition to the Sino-European College, the ESC and CSC have
joint collaboration at one another’s congresses. There are joint
sessions at our congress with your society and here we have had
joint sessions where we present new guidelines and new initiatives
to our Chinese colleagues.
Thus, our relationship with China has been extremely fruitful.
7. 026 门诊 CLINIC
东闻视野·国际瞭望 OUTLOOK
AHA2015｜Life is Why：尊重科学、关注患者
——2015年AHA科学年会开幕大典
LIFE IS WHY: RESPECT FOR SCIENCE, CARE FOR
PATIENTS——THE OPENING CEREMONY OF 2015
AHA ANNUAL MEETING
当地时间 11 月 8 日，美国佛罗里达州奥兰多市的橘郡会议中心里，美国心脏协会（AHA）2015 年科学年会
盛大开幕。在这座被喻为美国阳光之州的城市，AHA 携全球心血管领域的专家及学者共同关注为患者筑建无心脏
疾病的生活。在这一宗旨之下，AHA 会议包括临床医学、基础医学及人口科学三大部分，是心血管领域最为全面
及综合的科学会议之一。今天的开幕式上，AHA 传递出对科学无以复加的尊重。相信这份对科学和科学家的尊重，
是 AHA 真正做到立足于患者的根基。
10. 029门诊 CLINIC
AHA2015 HIGHLIGHTS AHA2015亮点撷英
AHA2015｜O'Gara教授解读新版STEMI指南：
关注指南亮点的意义在于立足临床
INTERPRETATION OF THE NEW VERSION STEMI
GUIDELINES BY O'GARA: KEY POINTS OF THE
GUIDELINES IS BASED ON CLINICAL
2015年11月10日，AHA科学年会最新临床试验板块的主
题是：ACS和PCI治疗。该板块的最后，由美国心脏病协会
（ACC）现任主席、来自波士顿布莱根妇女医院的Patrick
T.O'Gara教授作为压轴演讲对《2015年ACC/AHA/SCAI
STEMI患者急诊PCI指南》中的亮点进行解读。
本版指南做出了两个十分重大的更新，主要为改变了对
两种PCI治疗策略的推荐。STEMI患者PCI完全血运重建的推
荐级别上升，而STEMI患者PCI术前常规行血栓旋切抽吸术
的推荐级别下降。有趣的是，多支病变PCI完全血运重建曾
经是一个备受争议的话题，而现在其价值似乎越来越趋于明
朗。相反，血栓旋切抽吸术的获益过去未受到质疑，但如今
却不再列入指南优先推荐。虽然，讲究证据的循证医学本身
也存在争议的部分，但因为其客观性，确实是医学科学得以
发展的坚实基础。
O'Gara教授在演讲中解读指南更新所基于的大量循证；
也阐述对指南新推荐的正确理解。在演讲结束时O'Gara教
授指出：临床试验、循证数据和更新后的指南将如何改变美
国，甚至全球临床的诊疗策略，这才是最重要的。
《门诊》杂志前方特派记者为您完整呈现O'Gara教授
2015年AHA大会上的演讲，并深刻体味到O'Gara教授所传
达的思想：关注指南更新亮点的根本意义，在于立足临床。
Patrick T. O' Gara, MD
美国心脏病学会成员（FACC），美国心脏协会成员（FAHA）
ACC现任主席（2015年）
